Literature DB >> 29388191

Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.

G Zhang1, H Chen2, Y Gao1, Y Liu1, J Wang1, X Y Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29388191     DOI： 10.1111/bjd.16400

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Kaposiform hemangioendothelioma without cutaneous involvement.

Authors:  Yi Ji; Siyuan Chen; Lizhi Li; Kaiying Yang; Chunchao Xia; Li Li; Gang Yang; Feiteng Kong; Guoyan Lu; Xingtao Liu
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-06       Impact factor: 4.553

2.  Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: clinical characteristics and management.

Authors:  Yi Ji; Kaiying Yang; Siyuan Chen; Suhua Peng; Guoyan Lu; Xingtao Liu
Journal:  Cancer Manag Res       Date:  2018-09-07       Impact factor: 3.989

Review 3.  Kaposiform hemangioendothelioma: current knowledge and future perspectives.

Authors:  Yi Ji; Siyuan Chen; Kaiying Yang; Chunchao Xia; Li Li
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

4.  Case report: A rare case of retroperitoneal kaposiform hemangioendothelioma with spinal involvement without abnormal platelet count in 18F-FDG PET/CT.

Authors:  Yongkang Qiu; Zhao Chen; Qi Yang; Wenpeng Huang; Lele Song; Yan Fan; Lei Kang
Journal:  Front Med (Lausanne)       Date:  2022-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.